Advertisement

Topics

Latest "boston.com" News Stories

06:38 EDT 22nd May 2018 | BioPortfolio

Here are the most relevant search results for "boston.com" found in our extensive news archives from over 250 global news sources.

More Information about boston.com on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about boston.com for you to read. Along with our medical data and news we also list boston.com Clinical Trials, which are updated daily. BioPortfolio also has a large database of boston.com Companies for you to search.

Showing "boston" News Articles 1–25 of 1,600+

Tuesday 22nd May 2018

IHI Convenes Prominent Groups to Develop a National Action Plan for Patient Safety

New National Steering Committee for Patient Safety meets in Boston Aiming to relaunch the nation’s patient safety agenda with renewed energy and focus, the Institute for Healthcare Improvement (IHI) today hosts representatives from 24 organizations to begin work on a national strategy for reducing harm in the delivery of health care. The


4SC AG: 9 upcoming conferences and roadshows

DGAP-News: 4SC AG / Key word(s): Conference 22.05.2018 / 07:30 The issuer is solely responsible for the content of this announcement. 4SC AG: 9 upcoming conferences and roadshows Planegg-Martinsried, Germany, 22 May 2018 - 4SC AG (4SC, FSE Prime Standard: VSC) today announced its participation at upcoming conferences and roadshows. 4SC's management and scientists will be available for ...

Innovation Nation: Viscira® Digital Tour Continues Across the Country

Viscira’s 2018 Digital Innovation for Healthcare Roadshow Is Off to a Fast Start SAN FRANCISCO (PRWEB) May 22, 2018 Viscira, a leading provider of digital marketing solutions and software products for the life sciences industry, recently kicked off its second annual Digital Innovation Roadshow, titled “Innovation Nation.” The goal of the roadshow presentations is to help educate life scienc...


HRS 2018 Wrap-Up: Tendril Lead Failures; Metaanalysis of Contact-Force Catheter; LuxCath's OmniView; More Micra Results

The 2018 Heart Rhythm Society scientific sessions in Boston covered a variety of presentations of new electrophysiology clinical data, including...   

Monday 21st May 2018

Tweets Impression Analytics, Re-Tweets, Tweets and Likes by @AVIVA1950 and @pharma_BI for 2018 BioIT, Boston, 5/15 – 5/17, 2018

Tweets Impression Analytics, Re-Tweets, Tweets and Likes by @AVIVA1950 and @pharma_BI for 2018 BioIT, Boston, 5/15 – 5/17, 2018 Curator Aviva Lev-Ari, PhD, RN   This curation has four parts:   Part 1: Re-Tweets by @AVIVA1950  Part 2: Tweets earned impressions over 5/15 – 5/17/2018 Period – 2018 BioIT, Boston Part 3: Re-Tweets by @pharma_BI – see […]

Boston Strategic Partners, Inc. Authors Seven Posters for the International Society for Pharmacoeconomics Research (ISPOR) 2018 Conference

Boston Strategic Partners, Inc. authors seven posters for the International Society for Pharmacoeconomics Research (ISPOR) 2018 Conference, May 19-23 in Baltimore, MD BALTIMORE (PRWEB) May 21, 2018 Boston Strategic Partners, Inc (BSP) a global life-science consulting firm with comprehensive clinical, scientific, and business skills providing a multitude of high-value services to clients in indust...

OSHA Recognizes Cintas in Boston, MA with Highest Safety Designation

Cintas Corporation (NASDAQ: CTAS) today announced that its uniform rental location in Boston received Voluntary Protection Program (VPP) Star certification from the Occupational Safety and Health Administration (OSHA). The announcement took place during a special ceremony at Cintas. David Nangle, Massachusetts State Representative and Paul Cohen, Ch...

TxCell to Present at the First Treg Directed Therapies Summit

The Treg Directed Therapies Summit will take place in Boston on May 22-24, 2018 Regulatory News: TxCell SA (FR0010127662 TXCL) (Paris:TXCL), a developer of cellular immunotherapies based on regula...

#jobs #lifescience Controller Boston Technology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Controller Boston Technology .MA-Boston, Controller Boston Technology Boston-based SaaS/tech firm has an immediate need for a Controller on their growing team. The Controller will oversee the Accounting function … Continue reading → Cet article #jobs #lifescience C...

Critical Care Nurses Attending NTI 2018 Will Have Hands-On Preview of EchoNous’ New Vein Finding Tool

Pending FDA 510k clearance, new vein finding tool is designed to improve first-time peripheral IV (PIV) placement and help improve HCAHPS patient satisfaction scores EchoNous, a developer of intelligent medical tools and the parent company of Signostics, is a

SetPoint Medical Appoints Ankit Shah to Lead Commercialization and Marketing

– Commercialization Expertise Beneficial as SetPoint Advances its Clinical Program – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced today the appointment of Ankit Shah as Senior Director of Commercialization and Marketing. Mr. Shah has more than a...

HealthCore Announces First-Time Direct Access to its Research Data for Improved Insights and Decision Making

Life sciences companies can – for the first time – access one of the largest commercially insured population databases in the United States and find answers faster and more cost-effectively to questions, including whether they’re targeting the right populations for clinical trials, with the launch of HealthCore’s integrated database through Boston ...

Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System

- Company successfully continues to expand global IP portfolio to support strategic pathway for Pure-Vu® System to become standard of care Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the "Company"), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today that the Chinese Pate...

AACN brings together over thousands of nurses for annual conference

The American Association of Critical-Care Nurses brings together thousands of nurses this week in Boston at its annual National Teaching Institute & Critical Care Exposition with the theme "Guided by Why."

Sunday 20th May 2018

Scientists find link between increases in local temperature and antibiotic resistance

(Boston Children's Hospital) Bacteria have long been thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing. But could much bigger environmental pressures be at play?

Nutrition 2018 Preview: Hot Topics in Research and Practice

(Nutrition 2018) Journalists and bloggers are invited to join top scientists and practitioners as they discuss the latest nutrition research findings during Nutrition 2018, the inaugural flagship meeting of the American Society for Nutrition. The meeting will be held June 9-12, 2018 at the Hynes Convention Center in Boston.

Saturday 19th May 2018

Week in Review: Fosun in $2 Billion Bidding War for US Rights to Novartis' Generic Drugs

Deals and Financings  Fosun Pharma is one of the finalists in a $2 billion bidding war for part of Novartis' US portfolio of generic drugs; China Resources Pharma is in talks to pay $613 million for a controlling stake in Jiangzhong Group, a TCM company;   WuXi Biologics will build a $240 million CDMO facility in northern China's Shijiazhuang after announcing a $392 million biologics CD...

Zafgen Inc ZFGN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryZafgen Inc Zafgen is a biopharmaceutical company that develops therapeutics for patients suffering from obesity and related disorders. The company's product beloranib is a novel obesity therapy provided for obesity patients. It concentrates on targeting fat tissue to treat obesity. The company's pipeline products include, beloranib, ZGN839 and MetAP2i. Zafgen's obesity treatments include we...

Friday 18th May 2018

Incentivio Announces Its Partnership With American Deli® for Customer Engagement

BOSTON, May 18, 2018/PRNewswire/ -- Massachusetts-based Incentivio, Inc. today announced its partnership to power multi-channel customer engagement and digital ordering for participating American Deli® Read more...

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

PEABODY, Mass., May 18, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, today announced that it will launch the bkSpecto(TM) ultrasound system at the 113th AUA (American Urological Association) Annual Meeting, May 18-21, in San Francisco. bkSpecto-taken from the Latin word Specto, meaning 'I see&...

LaseMD Treatment in High Demand by Patients Worldwide

The latest innovation allows physicians to offer non-ablative skin resurfacing to every patient, regardless of skin type or age with minimal downtime BOSTON (PRWEB) May 18, 2018 Lutronic announced the availability of LaseMD, a 1927nm thulium laser. Designed with the physician in mind, the novel features range from the award-winning ergonomic design to the combined ease and speed of operation, whi...

Thursday 17th May 2018

There Are Other Places to Form Biotech Companies than Boston or San Francisco

Although it may be almost heresy to say it to venture capitalists and many research scientists, there are other places in the U.S. to form biotech companies than San Francisco and Boston.

2018 CHI’s BioIT World conference THURSDAY, MAY 17 | 8:00 – 9:45 AM – Awards and Keynote

« Synopsis for AI & Machine Learning in Clinical Trials, APRIL 12, 2018 PFIZER INNOVATION RESEARCH LAB – CAMBRIDGE, MA The Convergence of Medical Devices & Drugs: Advances in Drug Delivery May 3, 2018 12:00 PM – 5:00 PM, Westin Hotel, Waltham, MA » 2018 CHI’s BioIT World conference & Expo, May 15 – 17, 2018, Boston, MA – Seaport World Trade Center […]

Boston Mayor Martin J. Walsh Welcomes #BIO2018

On Wednesday, May 16, Boston Mayor Martin J. Walsh President joined BIO President and CEO, ...

bluebird bio to Present New Data from LentiGlobinTM Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease Clinical Studies at Annual Congress of the European Hematology Association

- Oral presentation of updated data from Phase 3 Northstar-2 (HGB-207) study of LentiGlobin in patients with transfusion-dependent β-thalassemia (TDT) and non-β0/β0 genotypes – - Oral presentation of interim data from patients treated with updated study protocol of Phase 1 HGB-206 study of LentiGlobin in patients with severe sickle cel...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks